MYX 1715

Pricing Availability   Qty
说明: N-myristoyltransferase (NMT) inhibitor
化学名: 4-[2-[2-[3-(2-Aminoethyl)imidazo[1,2-a]pyridin-6-yl]-5-chlorophenoxy]ethyl]-N,N,1,5-tetramethyl-1H-pyrazole-3-carboxamide dihydrochloride
纯度: ≥98% (HPLC)
说明书
引用文献
评论

生物活性 for MYX 1715

MYX 1715 is a N-myristoyltransferase inhibitor (NMT). MYX 1715 selectively kills senescent cancer cells in mouse models of paediatric pituitary tumors and liver cancer, and prevents tumor growth in mouse xenografts. In mouse models of idiopathic pulmonary fibrosis (IPF) and NASH, MYX 1715 reduces both lung and liver fibrosis, and decreases inflammation and steatosis.

技术数据 for MYX 1715

分子量 553.91
公式 C25H29ClN6O2.2HCl
储存 Store at -20°C
纯度 ≥98% (HPLC)
InChI Key IPOQBMAKZNXYNK-UHFFFAOYSA-N
Smiles O=C(N(C)C)C1=NN(C)C(C)=C1CCOC2=C(C3=CN4C(CCN)=CN=C4C=C3)C=CC(Cl)=C2.Cl.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for MYX 1715

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 55.39 100
water 55.39 100

制备储备液 for MYX 1715

以下数据基于产品分子量 553.91。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 1.81 mL 9.03 mL 18.05 mL
5 mM 0.36 mL 1.81 mL 3.61 mL
10 mM 0.18 mL 0.9 mL 1.81 mL
50 mM 0.04 mL 0.18 mL 0.36 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for MYX 1715

参考文献是支持产品生物活性的出版物。

McHugh et al (2023) COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. Nat.Cell Biol. 25 1804 PMID: 38012402


If you know of a relevant reference for MYX 1715, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Other Transferase Inhibitors

关键词: MYX 1715, MYX 1715 supplier, MYX1715, senescent, cancer, cells, tumor, steatosis, xenograft, non-alcoholic, steatohepatitis, idiopathic, pulmonary, fibrosis, in, vivo, IMP1320, Other, Transferases, 8109, Tocris Bioscience

篇 MYX 1715 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 MYX 1715 的引用文献。 您是否知道使用了 Tocris MYX 1715 的优秀论文? 请告知我们.

MYX 1715 的评论

目前没有该产品的评论。 Be the first to review MYX 1715 and earn rewards!

Have you used MYX 1715?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review